Value Set epSOSActiveIngredient 2013‑06‑03

1.3.6.1.4.1.12559.11.10.1.3.1.42.24

Effective Date

2013‑06‑03

Other versions this id:

epSOSActiveIngredient201711 - as of 2017‑11‑07 14:06:21

Status

Draft

Version Label

January 2010

Name

epSOSActiveIngredient

Display Name

epSOSActiveIngredient

Description

The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.

Source Code System

2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification

Level/ Type	Code	Display Name	Code System
0‑L	A	ALIMENTARY TRACT AND METABOLISM	WHO Anatomical Therapeutic Chemical classification
0‑L	A01	STOMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A01A	STOMATOLOGICAL PREPARATIONS	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA	Caries prophylactic agents	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA01	sodium fluoride	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA02	sodium monofluorophosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA03	olaflur	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA04	stannous fluoride	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AA51	sodium fluoride, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB	Antiinfectives and antiseptics for local oral treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB02	hydrogen peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB03	chlorhexidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB04	amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB05	polynoxylin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB06	domiphen	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB07	oxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB08	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB09	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB10	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB11	various	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB12	hexetidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB13	tetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB14	benzoxonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB15	tibezonium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB16	mepartricin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB17	metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB18	clotrimazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB19	sodium perborate	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB21	chlortetracycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB22	doxycycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AB23	minocycline	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC	Corticosteroids for local oral treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC01	triamcinolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC02	dexamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC03	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AC54	prednisolone, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD	Other agents for local oral treatment	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD01	epinephrine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD02	benzydamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD05	acetylsalicylic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD06	adrenalone	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD07	amlexanox	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD08	becaplermin	WHO Anatomical Therapeutic Chemical classification
0‑L	A01AD11	various	WHO Anatomical Therapeutic Chemical classification
0‑L	A02	DRUGS FOR ACID RELATED DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A02A	ANTACIDS	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA	Magnesium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA01	magnesium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA02	magnesium oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA03	magnesium peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA04	magnesium hydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA05	magnesium silicate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AA10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB	Aluminium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB01	aluminium hydroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB02	algeldrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB03	aluminium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB04	dihydroxialumini sodium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB05	aluminium acetoacetate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB06	aloglutamol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB07	aluminium glycinate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AB10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC	Calcium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC01	calcium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC02	calcium silicate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AC10	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD	Combinations and complexes of aluminium, calcium and magnesium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD01	ordinary salt combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD02	magaldrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD03	almagate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD04	hydrotalcite	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AD05	almasilate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF	Antacids with antiflatulents	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF01	magaldrate and antiflatulents	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AF02	ordinary salt combinations and antiflatulents	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AG	Antacids with antispasmodics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AH	Antacids with sodium bicarbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02AX	Antacids, other combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA	H2-receptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA01	cimetidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA02	ranitidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA03	famotidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA04	nizatidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA05	niperotidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA06	roxatidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA07	ranitidine bismuth citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA08	lafutidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA51	cimetidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BA53	famotidine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB	Prostaglandins	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB01	misoprostol	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BB02	enprostil	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC	Proton pump inhibitors	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC01	omeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC02	pantoprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC03	lansoprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC04	rabeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BC05	esomeprazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD	Combinations for eradication of Helicobacter pylori	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD01	omeprazole, amoxicillin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD02	lansoprazole, tetracycline and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD03	lansoprazole, amoxicillin and metronidazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD04	pantoprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD05	omeprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD06	esomeprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BD07	lansoprazole, amoxicillin and clarithromycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX01	carbenoxolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX02	sucralfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX03	pirenzepine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX04	methiosulfonium chloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX05	bismuth subcitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX06	proglumide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX07	gefarnate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX08	sulglicotide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX09	acetoxolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX10	zolimidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX11	troxipide	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX12	bismuth subnitrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX13	alginic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX51	carbenoxolone, combinations excl. psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX71	carbenoxolone, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02BX77	gefarnate, combinations with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A02X	OTHER DRUGS FOR ACID RELATED DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03	DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03A	DRUGS FOR FUNCTIONAL BOWEL DISORDERS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA	Synthetic anticholinergics, esters with tertiary amino group	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA01	oxyphencyclimine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA03	camylofin	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA04	mebeverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA05	trimebutine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA06	rociverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA07	dicycloverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA08	dihexyverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA09	difemerine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AA30	piperidolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB	Synthetic anticholinergics, quaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB01	benzilone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB02	glycopyrronium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB03	oxyphenonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB04	penthienate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB05	propantheline	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB06	otilonium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB07	methantheline	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB08	tridihexethyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB09	isopropamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB10	hexocyclium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB11	poldine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB12	mepenzolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB13	bevonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB14	pipenzolate	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB15	diphemanil	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB16	(2-benzhydryloxyethyl)diethyl-methylammonium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB17	tiemonium iodide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB18	prifinium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB19	timepidium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB21	fenpiverinium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AB53	oxyphenonium, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC	Synthetic antispasmodics, amides with tertiary amines	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC02	dimethylaminopropionylphenothiazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC04	nicofetamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AC05	tiropramide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD	Papaverine and derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD01	papaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD02	drotaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AD30	moxaverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE	Drugs acting on serotonin receptors	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE01	alosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE02	tegaserod	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE03	cilansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AE04	prucalopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX	Other drugs for functional bowel disorders	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX01	fenpiprane	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX02	diisopromine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX03	chlorbenzoxamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX04	pinaverium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX05	fenoverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX06	idanpramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX07	proxazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX08	alverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX09	trepibutone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX10	isometheptene	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX11	caroverine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX12	phloroglucinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX13	silicones	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX30	trimethyldiphenylpropylamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03AX58	alverine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A03B	BELLADONNA AND DERIVATIVES, PLAIN	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA	Belladonna alkaloids, tertiary amines	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA01	atropine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA03	hyoscyamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BA04	belladonna total alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB	Belladonna alkaloids, semisynthetic, quaternary ammonium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB01	butylscopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB02	methylatropine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB03	methylscopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB04	fentonium	WHO Anatomical Therapeutic Chemical classification
0‑L	A03BB05	cimetropium bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03C	ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA	Synthetic anticholinergic agents in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA01	isopropamide and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA02	clidinium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA03	oxyphencyclimine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA04	otilonium bromide and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA05	glycopyrronium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA06	bevonium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA07	ambutonium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA08	diphemanil and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA30	emepronium and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CA34	propantheline and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB	Belladonna and derivatives in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB01	methylscopolamine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB02	belladonna total alkaloids and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB03	atropine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB04	methylhomatropine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CB31	hyoscyamine and psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03CC	Other antispasmodics in combination with psycholeptics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03D	ANTISPASMODICS IN COMBINATION WITH ANALGESICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA	Synthetic anticholinergic agents in combination with analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA01	tropenzilone and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA02	pitofenone and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA03	bevonium and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA04	ciclonium and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA05	camylofin and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA06	trospium and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DA07	tiemonium iodide and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB	Belladonna and derivatives in combination with analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DB04	butylscopolamine and analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03DC	Other antispasmodics in combination with analgesics	WHO Anatomical Therapeutic Chemical classification
0‑L	A03E	ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS	WHO Anatomical Therapeutic Chemical classification
0‑L	A03EA	Antispasmodics, psycholeptics and analgesics in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A03ED	Antispasmodics in combination with other drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A03F	PROPULSIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA	Propulsives	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA01	metoclopramide	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA02	cisapride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA03	domperidone	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA04	bromopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA05	alizapride	WHO Anatomical Therapeutic Chemical classification
0‑L	A03FA06	clebopride	WHO Anatomical Therapeutic Chemical classification
0‑L	A04	ANTIEMETICS AND ANTINAUSEANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A04A	ANTIEMETICS AND ANTINAUSEANTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA	Serotonin (5HT3) antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA01	ondansetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA02	granisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA03	tropisetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA04	dolasetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AA05	palonosetron	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD	Other antiemetics	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD01	scopolamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD02	cerium oxalate	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD04	chlorobutanol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD05	metopimazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD10	dronabinol	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD11	nabilone	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD12	aprepitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD13	casopitant	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD51	scopolamine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A04AD54	chlorobutanol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A05	BILE AND LIVER THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	A05A	BILE THERAPY	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA	Bile acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA01	chenodeoxycholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA02	ursodeoxycholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AA03	cholic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB	Preparations for biliary tract therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AB01	nicotinyl methylamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX	Other drugs for bile therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX01	piprozolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX02	hymecromone	WHO Anatomical Therapeutic Chemical classification
0‑L	A05AX03	cyclobutyrol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05B	LIVER THERAPY, LIPOTROPICS	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA	Liver therapy	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA01	arginine glutamate	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA03	silymarin	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA04	citiolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA05	epomediol	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA06	ornithine oxoglurate	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA07	tidiacic arginine	WHO Anatomical Therapeutic Chemical classification
0‑L	A05BA08	glycyrrhizic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A05C	DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION	WHO Anatomical Therapeutic Chemical classification
0‑L	A06	LAXATIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A06A	LAXATIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA	Softeners, emollients	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA01	liquid paraffin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA02	docusate sodium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AA51	liquid paraffin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB	Contact laxatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB01	oxyphenisatine	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB02	bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB03	dantron	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB04	phenolphthalein	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB05	castor oil	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB06	senna glycosides	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB07	cascara	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB08	sodium picosulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB09	bisoxatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB20	contact laxatives in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB30	contact laxatives in combination with belladonna alkaloids	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB52	bisacodyl, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB53	dantron, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB56	senna glycosides, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB57	cascara, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AB58	sodium picosulfate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC	Bulk producers	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC01	ispaghula (psylla seeds)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC02	ethulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC03	sterculia	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC05	linseed	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC06	methylcellulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC07	triticum (wheat fibre)	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC08	polycarbophil calcium	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC51	ispaghula, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC53	sterculia, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AC55	linseed, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD	Osmotically acting laxatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD01	magnesium carbonate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD02	magnesium oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD03	magnesium peroxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD04	magnesium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD10	mineral salts in combination	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD11	lactulose	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD12	lactitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD13	sodium sulfate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD14	pentaerithrityl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD15	macrogol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD16	mannitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD17	sodium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD18	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD19	magnesium citrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD21	sodium tartrate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD61	lactulose, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AD65	macrogol, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG	Enemas	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG01	sodium phosphate	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG02	bisacodyl	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG03	dantron, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG04	glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG06	oil	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG07	sorbitol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG10	docusate sodium, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG11	laurilsulfate, incl. combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AG20	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH	Peripheral opioid receptor antagonists	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH01	methylnaltrexone bromide	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AH02	alvimopan	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX	Other laxatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX01	glycerol	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX02	carbon dioxide producing drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A06AX03	lubiprostone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07A	INTESTINAL ANTIINFECTIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA	Antibiotics	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA01	neomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA02	nystatin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA03	natamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA04	streptomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA05	polymyxin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA06	paromomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA07	amphotericin B	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA08	kanamycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA09	vancomycin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA10	colistin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA11	rifaximin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA51	neomycin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AA54	streptomycin, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB	Sulfonamides	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB02	phthalylsulfathiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB03	sulfaguanidine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AB04	succinylsulfathiazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC	Imidazole derivatives	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AC01	miconazole	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX	Other intestinal antiinfectives	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX01	broxyquinoline	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX02	acetarsol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX03	nifuroxazide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07AX04	nifurzide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07B	INTESTINAL ADSORBENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA	Charcoal preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA01	medicinal charcoal	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BA51	medicinal charcoal, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BB	Bismuth preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC	Other intestinal adsorbents	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC01	pectin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC02	kaolin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC03	crospovidone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC04	attapulgite	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC05	diosmectite	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07BC54	attapulgite, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07C	ELECTROLYTES WITH CARBOHYDRATES	WHO Anatomical Therapeutic Chemical classification
0‑L	A07CA	Oral rehydration salt formulations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07D	ANTIPROPULSIVES	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA	Antipropulsives	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA01	diphenoxylate	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA02	opium	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA03	loperamide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA04	difenoxin	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA05	loperamide oxide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA52	morphine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07DA53	loperamide, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07E	INTESTINAL ANTIINFLAMMATORY AGENTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA	Corticosteroids acting locally	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA01	prednisolone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA02	hydrocortisone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA03	prednisone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA04	betamethasone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA05	tixocortol	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA06	budesonide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EA07	beclometasone	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB	Antiallergic agents, excl. corticosteroids	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EB01	cromoglicic acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC	Aminosalicylic acid and similar agents	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC01	sulfasalazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC02	mesalazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC03	olsalazine	WHO Anatomical Therapeutic Chemical classification
0‑L	A07EC04	balsalazide	WHO Anatomical Therapeutic Chemical classification
0‑L	A07F	ANTIDIARRHEAL MICROORGANISMS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA	Antidiarrheal microorganisms	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA01	lactic acid producing organisms	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA02	saccharomyces boulardii	WHO Anatomical Therapeutic Chemical classification
0‑L	A07FA51	lactic acid producing organisms, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A07X	OTHER ANTIDIARRHEALS	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA	Other antidiarrheals	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA01	albumin tannate	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA02	ceratonia	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA03	calcium compounds	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA04	racecadotril	WHO Anatomical Therapeutic Chemical classification
0‑L	A07XA51	albumin tannate, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A08	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A08A	ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA	Centrally acting antiobesity products	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA01	phentermine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA02	fenfluramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA03	amfepramone	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA04	dexfenfluramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA05	mazindol	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA06	etilamfetamine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA07	cathine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA08	clobenzorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA09	mefenorex	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA10	sibutramine	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AA56	ephedrine, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB	Peripherally acting antiobesity products	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AB01	orlistat	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AX	Other antiobesity drugs	WHO Anatomical Therapeutic Chemical classification
0‑L	A08AX01	rimonabant	WHO Anatomical Therapeutic Chemical classification
0‑L	A09	DIGESTIVES, INCL. ENZYMES	WHO Anatomical Therapeutic Chemical classification
0‑L	A09A	DIGESTIVES, INCL. ENZYMES	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA	Enzyme preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA01	diastase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA02	multienzymes (lipase, protease etc.)	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA03	pepsin	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AA04	tilactase	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB	Acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB01	glutamic acid hydrochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB02	betaine hydrochloride	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB03	hydrochloric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AB04	citric acid	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC	Enzyme and acid preparations, combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC01	pepsin and acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A09AC02	multienzymes and acid preparations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10	DRUGS USED IN DIABETES	WHO Anatomical Therapeutic Chemical classification
0‑L	A10A	INSULINS AND ANALOGUES	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB	Insulins and analogues for injection, fast-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB04	insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB05	insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB06	insulin glulisine	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AB30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC	Insulins and analogues for injection, intermediate-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC04	insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AC30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD	Insulins and analogues for injection, intermediate-acting combined with fast-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD04	Insulin lispro	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD05	insulin aspart	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AD30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE	Insulins and analogues for injection, long-acting	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE02	insulin (beef)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE03	insulin (pork)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE04	insulin glargine	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE05	insulin detemir	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AE30	combinations	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF	Insulins and analogues for inhalation	WHO Anatomical Therapeutic Chemical classification
0‑L	A10AF01	insulin (human)	WHO Anatomical Therapeutic Chemical classification
0‑L	A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA	Biguanides	WHO Anatomical Therapeutic Chemical classification
0‑L	A10BA01	phenformin	WHO Anatomical Therapeutic Chemical classification
This value set has 5592 codes in it. In order to keep the publication size manageable, only a selection (500 codes) of the whole set of codes is shown.

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.

XML JSON CSV SQL SVS